Tapewire

Nasdaq · USD

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3441
SEC CIK
0001157601
Parsed reports
271

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025036
Dec 2025034
Jan 2026066
Feb 202600
Mar 2026017
Apr 202600
May 2026013
Jun 202601
Jul 2026010
Aug 202601
Sep 2026024
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 03, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 4,301 $244.58 $1,051,958.79
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 4

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,362

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.04 to $245.03, inclusive.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 2,294 $243.64 $558,920.94
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 3

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,663

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.00 to $243.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC SaleCommon Stock 185 $242.00 $44,770.00
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 2

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 212,957

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.

Read SEC document
April 03, 2024 Filed Apr 6, 2024 00:50 UTC Exercise / conversionCommon Stock 27,407 $9.45 $258,996.15
Disclosure

SEC source: 0000899243-24-000265 · doc4.xml · nonDerivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 11,212 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · derivative · entry 25

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,212 shares

Expires 2024-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 7 $249.05 $1,743.35
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 21

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,198

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 193 $248.49 $47,958.32
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 20

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,205

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.01 to $249.00, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 100 $246.88 $24,688.05
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 19

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,398

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.87 to $246.95, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 567 $246.20 $139,596.99
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 18

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,498

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.77 to $246.35, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 2,080 $244.97 $509,527.20
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 17

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,065

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.73 to $245.52, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 7,048 $244.27 $1,721,630.47
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 16

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,145

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.73 to $244.71, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 1,217 $243.28 $296,074.56
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 15

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,193

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.59 to $243.54, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionCommon Stock 11,212 $105.08 $1,178,156.96
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 14

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 10,912 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · derivative · entry 22

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,912 shares

Expires 2024-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 200 $248.45 $49,690.16
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 19

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,198

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $247.96 to $248.72, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 43 $247.03 $10,622.47
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 18

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,398

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.72 to $247.24, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 557 $246.30 $137,186.76
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 17

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,441

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $246.72 to $247.24, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 2,991 $244.89 $732,479.75
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 16

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,998

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.62 to $246.54, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 6,279 $244.19 $1,533,285.96
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 15

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,989

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.61 to $245.53, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 842 $243.26 $204,821.47
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 14

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,268

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $243.60 to $244.58, inclusive.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
Exercise / conversionCommon Stock 10,912 $105.08 $1,146,632.96
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 13

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,110

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.58 to $243.56, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 6,000 $0.00 Strike: $111.06 $0.00
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · derivative · entry 10

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2025-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $7.36 $0.00
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · derivative · entry 9

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 5,000 shares

Expires 2026-08-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC SaleCommon Stock 300 $267.07 $80,121.99
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 8

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,298

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.73 to $267.25, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC SaleCommon Stock 713 $265.28 $189,145.28
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 7

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,598

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.65 to $265.64, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC SaleCommon Stock 100 $259.07 $25,907.00
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 6

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,311

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC SaleCommon Stock 1,600 $257.93 $412,695.52
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 5

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,411

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.54 to $258.465, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC SaleCommon Stock 3,900 $256.88 $1,001,835.90
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 4

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,011

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.45 to $257.40, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC SaleCommon Stock 4,387 $255.90 $1,122,628.91
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 3

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,911

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.42 to $256.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC Exercise / conversionCommon Stock 6,000 $111.06 $666,360.00
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 2

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:47 UTC Exercise / conversionCommon Stock 5,000 $7.36 $36,800.00
Disclosure

SEC source: 0000950170-24-041528 · ownership.xml · nonDerivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,298

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 1,277 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · derivative · entry 24

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,212

Underlying: Common Stock · 1,277 shares

Expires 2024-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $100.45 $0.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · derivative · entry 23

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-06-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $9.45 $0.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · derivative · entry 22

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2026-07-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 274 $266.91 $73,132.02
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 13

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,198

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.73 to $267.21, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 700 $265.36 $185,748.99
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 12

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,472

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.04 to $265.64, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 116 $264.73 $30,709.18
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 11

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,172

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.00 to $264.85, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 143 $263.08 $37,620.67
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 10

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,288

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.00 to $263.98, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 841 $262.18 $220,493.13
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 9

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,431

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.95 to $262.82, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 200 $259.13 $51,826.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 8

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,272

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.11 to $259.15, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 2,104 $258.24 $543,339.48
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 7

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,472

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.02 to $258.93, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 2,790 $257.33 $717,940.10
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 6

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,576

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.01 to $258.00, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 7,411 $256.49 $1,900,850.35
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 5

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,366

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.01 to $256.99, inclusive.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
SaleCommon Stock 6,698 $255.62 $1,712,119.32
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 4

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,777

F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.01 to $256.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionCommon Stock 1,277 $105.08 $134,187.16
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 3

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionCommon Stock 10,000 $100.45 $1,004,500.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 2

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:44 UTC
BATE KENNETHDirector
Exercise / conversionCommon Stock 10,000 $9.45 $94,500.00
Disclosure

SEC source: 0000899243-24-000245 · doc4.xml · nonDerivative · entry 1

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 1,577 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · derivative · entry 21

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,912

Underlying: Common Stock · 1,577 shares

Expires 2024-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $100.45 $0.00
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · derivative · entry 20

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2024-06-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F18 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable.

Read SEC document
April 01, 2024 Filed Apr 4, 2024 00:41 UTC
Daly James MDirector
SaleCommon Stock 274 $266.91 $73,132.02
Disclosure

SEC source: 0000899243-24-000243 · doc4.xml · nonDerivative · entry 12

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,198

F1 · kind: (1) These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.73 to $267.21, inclusive.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.